معرفی
Isabelle Huys is a Professor at the Faculty of Pharmaceutical Sciences at KU Leuven. She serves as Vice-Rector for Research Policy and is affiliated with multiple institutes including the Center for IT & IP Law (CiTiP), KU Leuven Institute for Digital Society (DigiSoc), Institute for Rare Diseases (Leuven.IRD), Institute for Single Cell Omics (LISCO), and KU Leuven Cancer Institute (LKI).
- Research Focus: Regulatory sciences, market access for advanced therapies, rare diseases, biosimilar sustainability, and patient-centered decision-making frameworks.
- Leadership: Active in governance through roles in university councils, faculty boards, and research policy committees.
Her recent publications analyze EU pharmaceutical legislation reforms, biosimilar market dynamics, and clinical trial eligibility criteria. She leads projects like INFORM-RD (patient-informed clinical platforms for rare diseases) and 3Dose (3D-printed drug delivery systems).
Keywords: Clinical Pharmacology, Regulatory Affairs, Rare Diseases, Organoid Technology, Health Economics, Digital Health.